Société Carbylan Therapeutics Inc Nasdaq
Actions
US1413841073
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 26/03/04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01/08/16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 03/05/21 |
Ryan Baker
IRC | Investor Relations Contact | - | 01/05/23 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 25/07/23 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 01/11/16 |
Mike Smith
PRN | Corporate Officer/Principal | - | 01/02/16 |
Rachel Morten
LAW | General Counsel | - | 01/01/16 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 01/02/19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01/08/16 |
Albert Cha
BRD | Director/Board Member | 51 | 01/01/16 |
Edward Unkart
BRD | Director/Board Member | 74 | 01/12/14 |
Nancy Stuart
BRD | Director/Board Member | 65 | 18/03/21 |
Patrick Treanor
BRD | Director/Board Member | - | 26/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 42 188 296 | 41 670 541 ( 98,77 %) | 0 | 98,77 % |
Coordonnées société
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+0,82% | 93,19 Md | |
-1,32% | 39,62 Md | |
-12,23% | 33,78 Md | |
+64,77% | 26,82 Md | |
-15,93% | 15,35 Md | |
-6,15% | 13,13 Md | |
-11,38% | 11,6 Md | |
-49,19% | 10,26 Md | |
+5,24% | 9,43 Md |